[30-415-am] Cancer

Sat. Mar 30, 2024 9:45 AM - 10:45 AM [Room 415] Conference Center 415 (4F)

Chair: Kofuji Satoshi, Akifumi Kushiyama

+Add all to schedule

9:45 AM - 9:57 AM

[30-415-am06S] Pancreatic ductal adenocarcinoma cells induce endothelial mesenchymal transition

○Naoki Okamoto¹, Keigo Akuta¹, Nobuyuki Takakura¹ (1. Grad.Sch.Med.,Osaka Univ)

9:57 AM - 10:09 AM

[30-415-am07S] Study of PD-L1 expression in small cell lung cancer cells transfected with SRRM4-targeted antisense oligonucleotide

○Shunsuke Yoshimura¹, Ryota Suginaka², Takashi Aiba³, Masahito Shimojo², Satoshi Obika^1,2,4 (1. Sch. Pharm. Sci., Osaka Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. Luxna Biotech Co., Ltd., 4. OTRI, Osaka Univ.)

10:09 AM - 10:21 AM

[30-415-am08S] The role of RASL10A and FNDC3A regulating the malignant phenotypes of TNBC cell lines.

○Nanaka Wada¹, Satoshi Sakai², Makoto Nishizuka¹ (1. Fac. of Agri. and Life Sci., Hirosaki Univ., 2. Grad. Sch. Med., Hamamatsu Univ. Sch. of Med)

10:21 AM - 10:33 AM

[30-415-am09S] Exploration of adipogenic differentiation as a therapeutic potential in mesenchymal breast cancer cells

○Aina Tsujihana¹, Mito Murai¹, Ukina Isomoto¹, Momoko Kashiwagi¹, Rei Takahashi^1,2, Kiyotsugu Yoshikawa¹ (1. Pharm, DWCLA Univ., 2. Grad. Sch. Pharm., DWCLA Univ.)

10:33 AM - 10:45 AM

[30-415-am10S] Regulatory mechanism for cancer-related protein-targeting PROTACs by acetylated histone

○Rikuto Honda^1,2, Fumiaki Ohtake^1,2 (1. Inst. Advanced Life Sci., Hoshi Univ., 2. Sch. Pharm. Sci., Hoshi Univ.)